ABDULLAH A. ALANGARI
P.O. BOX 89805, RIYADH 11629, SAUDI ARABIA
MOBILE +966506287276 – EMAIL: ALANGARI100@GMAIL.COM
EDUCATION
5/2007 – 12/2007

6/2008 – 8/2008
Visiting Scholar
Division of Infection, Inflammation, and Repair
School of Medicine, University of Southampton
Southampton, UK
7/2000 – 6/2003

Fellow in Allergy & Immunology
Children’s Hospital
Harvard Medical School
Boston, Massachusetts, USA
6/1997 – 6/2000

Pediatric Resident
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts, USA
10/1994 – 4/1997

Pediatric Resident
King Fahad National Guard Hospital
Department of Pediatrics
Riyadh, Saudi Arabia
7/1993 – 7/1994

Intern
King Khalid University Hospital
King Saud University, College of Medicine
Riyadh, Saudi Arabia
9/1987 – 6/1993

Medical Student
King Saud University
College of Medicine
Riyadh, Saudi Arabia
1
CERTIFICATIONS
8/2003

American Board of Allergy and Immunolgoy
10/2000

American Board of Pediatrics
8/1995

MRCP (UK) Part 1 – Pediatrics
7/1993

MBBS with Honors
28/7/1999

The commonwealth of Massachuse tts – Board of
Registration in Medicine (USA).
Certificate No. 160993
13/1/2007

Saudi Commision for Health Specialties. Consultant
Pediatrician. Consultant Allergist, and Immunologist.
Registration ID No. 07-R-M-1150
LICENSURE
WORK EXPERIENCE
1/2015 - present

Professor of Pediatrics. College of Medicine, King Saud
Univeristy
10/2010 – 12/2014

Associate Professor of Pediatrics. College of Medicine, King
Saud University.
2005 – 9/2010

Assistant Professor of Pediatrics. College of Medicine, King
Saud University.
2004 - present

Consultant Pediatrician, Allergist, and Immunologis. King
Khalid University Hospital.
5/2005 – 11/2008

Head of the Allergy and Immunology Unit at the department
of Pediatrics, King Khalid University Hospital.
2009 – 2013

Member of the Pediatrics Allergy and Immunology Fellowship
Program’s Supervising committee.
2009 – 2013

Member of the mortality and morbidity committee, Dep. Of
Pediatrics, College of Medicine, King Saud University.
10/2009 – 8/2013
COMMITTEES
2
2005 – 2008

Chairman of the Undergraduate Teaching Program Committee,
Dept. of Pediatrics, College of Medicine, King Saud University.
ACADEMIES AND SOCIETIES AFFILIATION
 Fellow of the American Academy of Allergy and Immunology
 Member of the Saudi Scociety of Allergy and Immunology
 Member of the Saudi Pediatrics Association
PUBLICATIONS
 Charbonnier L-M, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, Massaad MJ,
Garcia-Lloret M, Hanna-Wakim R, Dbaibo G, Alangari AA, Alsultan A, AlZahrani D, Geha RS, Chatila TA. Regulatory T-cell deficiency and immune
dysregulation, polyendocrinopathy, enteropathy, X-linked–like disorder caused by
loss-of-function mutations in LRBA. J Allergy Clin Immunol. 2015;135:217-227
 Alangari AA, Riaz M, Mahjoub MO, Malhis N, Al-Tamimi S, Al-Modaihsh A. The
Effect of Sand Stroms on Acute Asthma in Riyadh, Saudi Arabia. Ann Thorac
Med.2015;10(1):29-33
 Alangari AA. Characteristics of Patients Presenting to the Emergency Department
with Anaphylaxis in Riyadh, Saudi Arabia. Journal of Taibah University Medical
Sciences.2014;9(4):318-321
 Alangari AA. Corticosteroids in the Treatment of Acute Asthma. Anna Thorac
Med.2014;9(4):187-192
 Al-Dosary K, Al-Qahtani A, Alangari AA. Anaphylaxis to Lidocain with Tolerance
to Articain in a 12 years old girl. Saudi Pharmaceutical Journal.2014;22:280-282
 Alangari AA, Malhis N, Mubashir M, Al-Ghamedi N, Al-Tannir M, Riaz M,
Umetsu DT, Al-Tamimi S. Budesonide Nebulization Added to Systemic
Prednisolone in The Treatment of Acute Asthma in Children: Doube-Blind,
Randomized, Controlled Trial. Chest.2014; 145(4):772-778
 Alangari AA. Normocomplementemic Urticarial Vasculitis in a Boy and his
Response to Treatment. Curr Pediatr Res.2014;18(1):8-10
 Alfares FA, Raddaui EM, El-Mozan MI, Alangari AA. Menetrier’s disease in a
Saudi child. Saudi Med J.2013;34(11):1192-4
 Alangari AA, Alsultan A, Osman M, Anazi S, Alkuraya F. A Novel Homozygous
Mutation in G6PC3 Presenting as Cyclic Neutropenia and Severe Congenital
3
Neutropenia in the Same Family. J Clin Immunol.2013;33(8):1403-6
 Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, et al.
Inherited IL-12p40 Deficiency: Genetic, Immunologic, and Clinical Features of 49
Patients From 30 Kindreds. Medicine (Baltimore). 2013;92:109-122 [Erratum.
Medicine (Baltimore). 2013;92:190]
 Book Chaper: Alangari AA. The Use of Glucocorticoids in the Treatment of
Acute Asthma Exacerbations. In: Qian, X, eds. Glucocorticoids-new recognistion
of our familiar friend. In tech; 2012.501-522 p.
 Al-Khayyat A, Al-Anazi M, Warsy A, Vazquez-Tello A, Alamri AM, Halwani
R, Alangari AA, Al-Frayh A, Hamid Q, Al-Muhsen S. T1 and T2 ADAM33 single
nucleotide polymorphisms and the risk of childhood asthma in a Saudi Arabian
population: a pilot study. Ann Saudi Med.2012;32:479-486
 Alangari AA, Alsultan A, Adly N, Massad M, Kiani IS, Aljebreen A, et al. LPSresponsive beige-like anchor (LRBA) gene mutation in a family with inflammatory
bowel disease and combined immunodeficiency. J Allergy Clin Immunol.
2012;130:481-8
 Shaffiq A, Haitchi H-M, Pang Y, Alangari AA, Jones M, Marshall B, Howarth P,
O’Reilly K, Davies D. A Disintegrin And Metalloprotease (ADAM)33 Protein in
Patients with Sarcoidosis. Respirology. 2012;17:342-349
 Sancho-Shimizu V, de Diego RP, Lorenzo L, Halwani R, Alangari AA, et al.
Herpes simplex encephalitis in patients with autosomal recessive and dominant
TRIF deficiency. J Clin Invest. 2011;121:4889-4902

Alangari AA, Al-Zamil F, Al-Mazrou A, Al-Muhsen S, Boisson-Dupuis S,
Awadallah S, Kambal A, Casanova J-L. Treatment of disseminated mycobacterial
infectionwith high dose IFN- in a patient with IL-12R1 deficiency. Clin Dev
Immunol.2011, doi:10.1155/2011/691956

Alangari AA. Genomic and non-genomic actions of glucocorticoids in asthma.
Ann Thorac Med. 2010;5:133-39

de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S,
Feinberg J, et al. Revisiting human IL-12Rb1 deficiency: a survey of 140 patients
from 30 countries. Medicine (Baltimore). 2010;89:381-402

Cote M, Menager M, Burgess A, Mahlaoui N, Picard C, Schaffner C, Al-Manjomi
F, Al-Harbi M, Alangari A, et al. Munc18-2 deficiency casuses familial
hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule
exocytosis in patient NK cells. J Clin Invest. 2009;119:3765-73

Alangari AA, Al-Harbi A, Al-Ghonaium A, Santisteban I, Hershfield M. Purine
nucleoside phosphorylase deficiency in Two Unrelated Saudi Patients. Ann Saudi
Med. 2009;29:309-312
4

Alangari AA. Students’ perception of the pediatrics course in a Saudi Medical
School. J T U Med Sc. 2008;3(2):135-139

Alangari AA, Abutaleb M, Albarraq A, Al-Dhowailie. Immediate adverse reactions
of intravenous immunoglobulins. Cur Pediatr Res. 2008;12:31-34

Alangari AA, Abutaleb M, Albarraq A, Al-Dhowailie. Intravenous
immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia.
Saudi Med J. 2008;27:477-481

Alangari AA, Lau LC, Zhou XY, Mochizuki A, Salagean EM, Salib RJ, Howarth
PH, Walls AF. Differential Release and Clearance of Mast Cell and Basophil
Mediators in the Uper Airways of Patients with Allergic Rhinitis. J Allergy Clin
Immunol. 2008;121(2):S152

Zhou XY, Lau LC, Tabares CM, Alangari AA, Summers C, Pumphrey RS, Wild
G, Escribano L, Walls AF. Mast cell proteases as new clinical markers of
anaphylaxis and mastocytosis. Abstract presented at the MRC meeting in
Edinburgh, UK. September, 2007

Alangari AA, Abobaker A, Kanegane H, Miyawaki T. X-linked
Lymphoproliferative Disease Associated with Hypogammaglobulinemia and
Growth Hormone Deficiency. Eur J Pediatr. 2006;165:-165-167

Alangari AA, Twarog FJ, Shih M-C, Schneider LC. Clinical Features and
Anaphylaxis in Children with Cold Urticaria. Pediatrics. 2004;113:e313-e317

Leung DYM, Sampson HA, Yunginger A, Burks AW, Schneider LC, Wortel CH,
et al. Effect of Anti-IgE Therapy in Patients with Peanut Allergy. N Engl J Med.
2003; 13; 348:986-993 (among the TNX-901 peanut allergy study group)

Alangari A, Schneider L, Geha R, Nurko S, Bonilla F. Primary Sclerosing
Cholangitis in a Patient with Possible Hyper-IgE Syndrome. J Allergy Clin
Immunol. 2002; 109(1):S192
RESEARCH GRANTS AWARDED
2013

Grant source: King Abdulaziz City for Science and
Technology.
Project number: 12-NAN2537-02. Title: Design, development and
evaluation of a nano- transdermal (needle-free) allergy test for
diagnosis of type-1 hypersensitivity. (Co-investigator)
2012

Grant source: Deanship for Scientific Research, King Saud
University.
Project number: RGP-VPP-190. Title: The immunomodulatory
properties of honey. (Primary Investigator)
5
2010

Grant source: King Abdulaziz City for Science and
Technology.
Project number: 08-MED520-02. Title: The use of inhaled
corticosteroids in the treatment of acute asthma in children in the
emergency room. (Primary investigator)
2008

Grant source: King Abdulaziz City for Science and
Technology – Summer grant.
Project title: The Role of ADAM33 in Asthma. (Co-investigator)
2007

Grant source: British Council.
Project Title: Investigation of the Potential for Differential
Activation of Mast Cells and Basophils using new Assays
for Biochemical Markers.(Co-investigator)
2006

Grant source: Research Center, College of Medicine, King
Saud University.
Project Number: 05-519. Title: The role of IFN- in the
treatment of disseminated mycobacterial infection in
patients with IL-12R1 deficiency.(Primary investigator)
2005

Grant source: King Abdulaziz City for Science and
Technology.
Project Number: 10-26-420. Title: Genotyping and
phenotyping of Saudi patients with chronic granulomatous
disease. (Co-investigator)
6